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Abstract
Background: The aim of this study was to assess total femur replacement for the treatment of femoral osteosarcomas.
Methods: Between January 1995 and January 2012, 21 patients with a mean age of 21.8 years old were treated for
femoral osteosarcomas with total femur replacement. All tumors were staged according to Enneking’s criteria with one
stage IIA case and 20 stage IIB cases.
Results: The survival of patients with osteosarcoma without metastases was 66.7 % at 5 years. Twelve patients were
alive with an overall mean follow-up of 71.2 months, and the mean postoperative functional score was 72.5 % at
their last follow-up. Superficial infection occurred in two patients, which were resolved by changing dressing and
intravenous antibiotics. Deep infection occurred in one patient, which was an amputation by hip disarticulation. Patella
fracture occurred in one patient, which was treated by open reduction and tension band fixation. Local recurrence was
seen in one patient, which was an amputation by hip disarticulation. Pulmonary metastases were observed in nine
patients and all the patients subsequently died of disease within 12 months. Aseptic loosening in tibial stem occurred
in three patients, whose whole prosthesis was revised.
Conclusions: Total femur replacement is a reliable method to restore mechanical and functional results after extensive
resection of the femur.
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Background
Tumors involving the whole femur present a challenge
when limb salvage is considered. These tumors are often
large, and resection involves removal of the whole femur
with disruption of the hip abductor mechanism [1–3].
Extensive soft-tissue dissection and reconstruction of the
joint above and below are required.
Total femoral replacement can restore femoral integ-
rity and allow patients to resume ambulation, albeit at a
compromised level. In addition, limb-preserving surgery
is better accepted by patients, is more cost-effective in
the long term, and is associated with significantly lower
oxygen consumption and energy requirements per meter
walked compared to amputation [1, 2]. Moreover, pa-
tients’ survival is not improved by amputation [3].
In this study, we carried out a retrospective review of
patients treated with total femur replacement in our
institute to identify the factors that affect survival, compli-
cations, and function following total femur replacement.
Methods
We retrospectively reviewed 21 patients who under-
went total femur replacement between January 1995
and January 2012 in our institute (Table 1). All cases
of tumors were staged according to Enneking’s cri-
teria with one stage IIA case and 20 stage IIB cases.
This study was approved by the Second Xiangya Hospital
committee for clinical research (no. 2012-S231), and in-
formed consent was obtained from the patients participat-
ing in the study. The patients provided written informed
consent for the publication of individual clinical details
and accompanying images.
We performed total femur replacement based on imaging
and histology. Only patients with tumor involving all or
most of the femur and for which no other reconstruction
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option was deemed feasible were selected for the study
[1–3]. Magnetic resonance imaging (MRI) was used
to ensure that the neurovascular bundle was not
encased by the tumor. Of the 21 patients with total
femur replacement, there were 13 male and 8 female
patients with ages ranging from 15 to 38 years (average:
21.8 years). The histological diagnoses were high-grade
osteosarcoma in all patients. One of the patients required
total femur replacement because of the failure of previous
limb salvage surgery. Eight years ago, his distal femur was
removed and knee prosthesis was placed because of
osteosarcoma. Pain and swelling were the most common
symptoms. The average duration of time between onset of
symptoms and diagnosis was 4.3 months (range 2 to
7 months). All patients received preoperative chemother-
apies with a high dose of methotrexate, doxorubicin,
cisplatin, and ifosfamide.
Before resection, a biopsy was performed in all pa-
tients and systematic examinations were evaluated to de-
termine the extent of the local disease and to distinguish
the presence of metastasis, including clinical assessment,
plain radiograph, SPECT scan, and chest radiograph and
computed tomography (CT) scans. MRI was also per-
formed to define the degree of the tumor, involvement
of the soft tissues, particularly the neurovascular bundle,
and the level of bone resection. At diagnosis, there were
no patients that presented with lung metastases.
The degree of tumor necrosis in response to the pre-
operative chemotherapy was rated according to the
Huvos grading system [4]. Eighteen patients had a grade
IV response (complete tumor necrosis), and three had
grade III response (more than 90 % necrosis). All the
patients received postoperative chemotherapies.
A custom-made total femur prosthesis (Chunli Co.
Ltd, Beijing, China), which utilizes a bipolar femoral head
component and a fixed hinge, cemented, constrained total
knee system, was used for this method.
The operation consisted of two main steps: en bloc
excision of the tumor and reconstruction of the defect
by total femur prosthesis (Figs. 1 and 2) [1, 2]. The
Watson–Jones approach to the hip was used, with a
long incision on the lateral side of the thigh. The glu-
teus medius and minimus, together with the external
rotators, were detached depending on the surgical margin
[1, 2]. The gluteus maximus tendon was divided, and the
sciatic nerve was exposed and protected. Part of the quad-
ricep was excised with the tumor according to standard
oncologic surgical principles; the vastus intermedius
muscle was excised en bloc while rectus femoris was pre-
served to enhance hip flexion and knee extension [1, 2].
Table 1 Clinical data from osteosarcoma patients with total femoral reconstruction










1 17/M Stage IIB No Conservative (69) No 89 Death, 80
2 15/M Stage IIB No No Aspetic loosening (1,138) 80 Alive, 192
3 24/F Stage IIB No Conservative (27) No 63 Death, 38
4 30/F Stage IIB No (amputation
due to infection)
No No 50 Alive, 157
5 18/M Stage IIB No Conservative (51) 81 Death, 63
6 26/M Stage IIB No No Aspetic loosening (1,105) 73 Alive, 121
7 19/F Stage IIB Amputation (25) Conservative (37) No 43 Death, 48
8 21/M Stage IIA No No Aspetic loosening (1,90) 85 Alive, 97
9 17/F Stage IIB No Conservative (31) No 55 Death,39
10 26/M Stage IIB No No Patella fracture (1,72) 72 Alive, 87
11 22/M Stage IIB No Conservative (45) No 75 Death, 53
12 24/F Stage IIB No No No 83 Alive, 75
13 18/M Stage IIB No No No 58 Alive, 65
14 20/M Stage IIB No Conservative (47) No 79 Death, 56
15 22/M Stage IIB No No No 86 Alive, 62
16 23/F Stage IIB No Conservative (23) No 65 Death, 31
17 20/M Stage IIB No No No 78 Alive, 55
18 22/F Stage IIB No No No 80 Alive, 51
19 17/F Stage IIB No Conservative (38) No 73 Death, 45
20 38/M Stage IIB No No No 69 Alive, 43
21 19/M Stage IIB No No No 85 Alive, 37
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The capsule of the hip was detached circumferentially
from the femoral neck depending on the surgical margin
and the femoral head dislocated; the insertion of the psoas
was divided. To obtain reasonable stability of the pros-
thesis and adequate hip abduction, the greater trochanter
with its attached abductors was osteotomized when the
surgical margin was allowed [1, 2]. The osteotomized
greater trochanter would later reattach to the prosthesis
[1, 2]. Distally, the patella was dislocated medially. The
neurovascular bundle was exposed and separated from the
tumor, with ligation of the vessels passing to the tumor
and the femur. Muscles attached to the linea aspera were
divided together with the insertion of the adductor mag-
nus. The femur was then removed after division of the
capsule at the knee. The proximal tibia was osteotomized
and reamed for the press-fit insertion of the tibial compo-
nent. The parts were then assembled, and a trial reduction
was carried out to test stability and tension. The re-
maining hip capsule was sutured around the neck of the
prosthesis. The capsule was reinforced by rotating the
external rotator muscles proximally and suturing them to
the repaired capsule. The remaining psoas muscle was ro-
tated anteriorly to close and reinforce the capsular repair.
If the greater trochanter was resected en bloc with
the surgical specimen, the remaining abductors were
brought down to the proximal aspect of the pros-
thesis and attached to a metal loop. If a fragment of
the great trochanter remained, it was fixed to the
prosthesis. Meticulous hemostasis is essential, and the
dead space was eliminated as much as possible. The
endoprosthesis was covered with the remaining muscles,
and the wound was closed in layers over large-bore suc-
tion drains [1, 2].
All patients were given intravenous broad-spectrum
antibiotics postoperatively. Patients were asked to follow-
up every month in the first year, then every 3 months for
the following 2 years, and then every 6 months. A CT scan
of the chest was performed every 3 months in the first
year and then every 6 months to exclude pulmonary me-
tastases. A bone scan was performed every 6 months in
the first year and then annually until the last follow-up.
Functional status was assessed using the Musculoskeletal
Tumor Society Scoring system (MSTS) [5]. For the radio-
graphic evaluation of the prosthesis, the International
Society of Limb Salvage (ISOLS) method was used [1]. For
radiographic evaluation of the hip, the method of Morris
et al. [1] was used.
Fig. 2 Treated with complete excision of the femur and total
femoral endoprosthetic replacement. The patient is alive with no
evidence of disease at 43 months
Fig. 1 Total femoral custom prosthesis replacement after complete
excision of the femur intra-operatively
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Results
No patient was lost in the follow-up. The survival of
patients with a primary osteosarcoma without metasta-
ses was 66.7 % at 5 years. Twelve patients (57.1 %) were
alive with an overall mean follow-up of 71.2 months
(range 37–192 months). There were four males (4/13,
30.77 %) and five females (5/8, 62.5 %) who died; there
was a significant difference between the mortality rate of
male and female (P < 0.05) (Fig. 3).
Superficial infection occurred in two patients (2/21,
9.5 %), which were resolved by changing dressing and
intravenous antibiotics. Deep infection occurred in one
patient (1/21, 4.8 %), which was an amputation by hip
disarticulation. Patella fracture occurred in one patient
(1/21, 4.8 %), 72 months after total femur replacement
due to an accidental fall, which was treated by open
reduction and tension band fixation. Local recurrence
was seen in one patient (1/21, 4.8 %), 25 months after
operation, which was an amputation by hip disarticula-
tion. Unfortunately, the patient had pulmonary metasta-
sis 37 months after operation and died 48 months after
operation (case 7). Pulmonary metastases were observed
in nine patients (9/21, 42.9 %). Metastases were rated as
unrespectable due to dissemination, and all the patients
subsequently died of disease within 12 months. There
was no surgery indication for these patients with metas-
tases. Aseptic loosening in tibial stem occurred in three
patients (3/21, 14.3 %) whose whole prosthesis was
revised.
Competence of the extensor mechanism is the major
determinant of functional outcome of these patients.
Eleven patients (11/21, 52.4) could walk without crutches,
while other patients needed some sort of support to walk.
According to Enneking’s functional evaluation method [5],
the mean postoperative functional score was 72.5 % (range
43–89 %) at their last follow-up, and the male patients’
mean functional scores were higher than the females’
(P < 0.05) (Fig. 3). Using the ISOLS radiographic evalu-
ation method [1], all the available radiographs showed
excellent results. Excellent results were also seen for the
radiographic evaluation of the reconstructed hip according
to the method of Morris et al. [1].
Discussion
Our results of 21 total femur replacements for osteosar-
coma showed good oncological and functional outcomes,
though the survival rate of patients was only 66.7 % at
5 years.
In this study, we note several limitations. A major
limitation of this study presented a selective series. Total
femur replacement is not a common procedure, and
thus, indications are not well defined [1–3]. A high-
grade malignant sarcoma (stage IIB), with a proposed
30 % incidence of skip lesions, has been the indication
for this procedure [1, 2, 6]. The nearby soft tissue tumor
involving all or most of the femur is another indication
[1–3]. Total femur replacement is also indicated in pa-
tients with a recurrent malignant tumor or a metastatic
lesion involving a large segment of the femur. Total
femur replacement would provide those patients with a
functional limb and remain pain free in their remaining
life [1–3]. In addition, total femur replacement could be
Fig. 3 a Functional evaluation showed the male patients’ mean functional scores (77.7 %) were higher than the females’ (64 %) (*P < 0.05);
b Complication rate diagram showed that pulmonary metastasis was much higher than others; c The female patients’ mortality rate (62.5 %) was
higher than male patients’ (30.77 %) (*P < 0.05); d Survival proportions of patients
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required as a revision surgery after the failure of previ-
ous limb salvage surgery or arthroplasty [1, 3, 6]. In the
present study, surgery was performed using total femur
replacement for 20 primary osteosarcomas and one with
recurrent osteosarcoma.
The total femur prosthesis is not a novel concept.
However, most of the reports on this topic either had
extremely small patient cohorts or did not adequately
address function outcomes.
Ahmed [2] treated nine consecutive patients by total
femur resection and reconstruction with total femur
replacement. After a mean follow-up of 51 months, the
MSTS functional score ranged from 30 to 93 %. Kalra
et al. [3] reported on 26 consecutive patients with total
femur endoprostheses after tumor excision. After a
mean follow-up of 57 months, the nine patients alive
with no evidence of disease had a mean MSTS func-
tional score of 72 %. Morris et al. [1] reported on seven
patients who underwent total femur replacement. Clin-
ical and radiological results were excellent or good at
final follow-up at an average of 23 months. Natarajan
et al. [7] analyzed 17 patients with primary malignant
bone tumor of the femur who underwent total femur
replacement. The average follow-up period was
54.05 months with the longest being 168 months.
The average MSTS functional score was 66.6 %. Ward
et al. [8] reported on 21 patients with total femoral
replacements. Two patients with tumors died within
2 months. The results in the 19 longer-term survivors
were satisfactory in 16 patients (good in seven, fair in
nine) and poor in three. Sewell et al. [9] undertook a
retrospective review of 33 patients who underwent
total femoral endoprosthetic replacement as limb salvage
following excision of a malignant bone tumor. The mean
follow-up was 4.2 years, and the mean MTST score
was 67 %. In our study, the mean MTST functional
score of 72.5 % at the last follow-up was comparable
with that of the above mentioned studies. Interest-
ingly, in the present study, the male patients’ func-
tional scores were higher than the females’, maybe the
male patients exercised more than the females post-
operation.
Osteotomising the greater trochanter and its reattach-
ment with its abductors to the prosthesis is a good
method for maintaining the hip abduction and to pro-
vide soft-tissue stability to the reconstructured hip, pro-
vided that it will not compromise the surgical margin
[2]. If resection of the trochanter or the abductors is in-
dicated, then reattachment of the remaining abductors
to the prosthesis and moreover to the tensor fascia lata
is another alternative to maintain hip stability and to im-
prove the gait [2]. However, Morris et al. [1] suggested
that reattachment of the abductors to the endoprosthesis
often fails, and therefore, they suture the abductors to the
fascia lata. They also emphasized that the rectus femoris
should be saved, if possible.
Frieseke et al. [10] published the largest known series
of total femur prostheses use for aseptic failure of a hip
or knee arthroplasty. Prostheses were implanted during
revision arthroplasty in 100 consecutive patients without
infection. Of the complications experienced by patients,
the most frequent was periprosthetic infection, which
occurred in 13 % of patients. In the report by Kalra et al.
[3], the deep infection rate was 7 %, which was similar
to the report by Nerubay et al. [11]. In Natarajan et al.’s
series [7], the deep infection rate was 11.8 %, while in
our series, the deep infection rate was 4.8 % (one out of
21). In our notion, the high infection rate was attributed
to the large extent of the wound, size of the implant,
and chemotherapy.
There was no hip dislocation in our series, while the
hip dislocation rate was 11 % in Kalra et al.’s report [3].
Kalra et al. [3] suggested that a rotating hinge design at
the knee should be avoided in patients with total femur
replacement since rotation at the knee can lead to hip
dislocation. In our study, we adopted a fixed hinge
design at knee and a bipolar femoral head component
since this allows the use of a larger femoral head.
However, we note that preservation of the acetabulum
and hip joint capsule and capsulorrhaphy over the
prosthetic head are major factors in stabilization and
prevention of dislocation. Stability is also enhanced
by attaching of the abductors and psoas muscle to
prosthesis.
Conclusions
We believe that our series presents the results of what
can be expected in the long term for patients with osteo-
sarcomas who require total femur replacement. This
form of reconstruction provides predictable results after
excisions of the femur for osteosarcomas. The oncology
and functional results would imply that this procedure is
an excellent method of limb salvage for massive excisions
of femoral osteosarcomas.
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